| Revenue growth | FY27 guided at ₹2,200-2,400cr. |
|---|---|
| Margins | Targeting 12-14% EBITDA for FY27 vs 5% in Q4. |
| Order book | Large order book across businesses; 300 MT Ethyl Vanillin for Q1. |
| Demand visibility | Strong order book for Ethyl Vanillin; 50% of campaign covered. |
| Management confidence | High on Blends and Vanillin scaling despite macro headwinds. |
Growth
FY26 revenue reached ₹1,723cr; Blends grew 17% (18% including Europe). Q4 EBITDA at ₹21cr (5% margin).
Outlook
FY27 revenue guidance ₹2,200-2,400cr with 12-14% EBITDA margins. Vanillin volume target 2,200-2,400 MT for U.S.
Risks
Geopolitical conflicts causing 20% shipment delays, high freight costs, and raw material (Phenol/Caustic) price spikes.
Earnings Call filed with BSE, NSE: CAMLINFINE. Summary written with AI assistance from the document.
Camlin Fine Sciences Ltd: key numbers
- Share price
- ₹97.30
- Market cap
- ₹1,869 Cr
- Revenue (annual)
- ₹1,723 Cr
- Net profit (annual)
- ₹27.63 Cr
- P/E (TTM)
- 317.8×Sector 37.5×
- Promoter holding
- 48.03%+0.00% QoQ
- FII holding
- 0.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Camlin Fine Sciences Ltd
All →Camlin Fine Sciences Annual General Meeting
Camlin Fine Sciences filed a Postal Ballot Notice seeking approval to appoint Mr. Atul Pradhan as Non-Executive Independent Director. E-voting runs September 17 to October 16, 2026.
Camlin Fine Sciences Management Change
Camlin Fine Sciences appointed Mr. Atul Pradhan as Additional Non-Executive Independent Director effective September 11, 2026. The appointment is subject to shareholder approval via postal ballot.
Camlin Fine Sciences Earnings Call Transcript: Key Takeaways
Camlin Fine Sciences reported Q1 FY27 revenue of INR 5,199 million, up 28% YoY, though EBITDA margins were pressured to 4% by high raw material and freight costs.
- Call
- Guides 25% growth
Camlin Fine Sciences Investor Presentation: Key Takeaways
Camlin Fine Sciences reported record quarterly revenue of Rs 5,199 Mn for Q1FY27, up 27.5% YoY, driven by strong growth in Specialty Ingredients and Aroma segments.
Camlin Fine Sciences Q1 FY27 Results: Net Loss of ₹33.6 Cr, Loss Widens
Camlin Fine Sciences Ltd reported revenue from operations of ₹519.9 Cr (+27.5% YoY) and a net loss of ₹33.6 Cr for Q1 FY27.
- Key figure
- Net loss ₹33.6 Cr
Camlin Fine Sciences Earnings Call: Key Takeaways
CFS reported FY26 revenue of ₹17,233 mn (6% YoY growth) with an EBITDA margin of 6.2%. The company is pivoting towards high-value Blends and acquired Vinpai to diversify into natural ingredients.